Cogent Biosciences (COGT) Retained Earnings: 2017-2021
Historic Retained Earnings for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to -$246.1 million.
- Cogent Biosciences' Retained Earnings fell 31.35% to -$246.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$246.1 million, marking a year-over-year decrease of 31.35%. This contributed to the annual value of -$198.7 million for FY2020, which is 60.38% down from last year.
- As of Q3 2021, Cogent Biosciences' Retained Earnings stood at -$246.1 million, which was down 8.41% from -$227.0 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Retained Earnings ranged from a high of -$51.3 million in Q4 2017 and a low of -$246.1 million during Q3 2021.
- In the last 3 years, Cogent Biosciences' Retained Earnings had a median value of -$137.4 million in 2020 and averaged -$164.1 million.
- Data for Cogent Biosciences' Retained Earnings shows a maximum YoY crashed of 79.32% (in 2018) over the last 5 years.
- Cogent Biosciences' Retained Earnings (Quarterly) stood at -$51.3 million in 2017, then tumbled by 79.32% to -$92.1 million in 2018, then slumped by 34.58% to -$123.9 million in 2019, then crashed by 60.38% to -$198.7 million in 2020, then crashed by 31.35% to -$246.1 million in 2021.
- Its last three reported values are -$246.1 million in Q3 2021, -$227.0 million for Q2 2021, and -$210.4 million during Q1 2021.